Leadership

ACRO is led by a distinguished team of industry, drug development, and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, efficient, and effective clinical trials that protect patients and ensure high-quality results.

All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is comprised of the current ACRO Chair, Vice-Chair, and immediate Past-Chair.

Board of Directors

Catherine Gregor

Chief Clinical Trial Officer, Florence Healthcare

Kate Haven

Vice President of Investor Relations, ICON plc

Peyton Howell

Chief Executive Officer, Parexel

Karen Kaucic

President, Patient and Advisory Services & Chief Medical Officer, Clinical Research, PPD, Part of Thermo Fisher Scientific

Margaret Keegan

Chief Executive Officer, Precision Medicine Group

Sandy Kennedy

Chief Quality, Regulatory Affairs, & Sustainability Officer, Fortrea

Chair

Lisa Moneymaker

Chief Strategy Officer

Jim Reilly

Vice President, Vault R&D, Veeva

Gadi Saarony

CEO, Advarra

Vice-Chair

Seema Verma

SVP & GM, Oracle Life Sciences

Cynthia Verst

President, Design & Delivery Innovation, Research & Development Solutions, IQVIA

ACRO Staff

Clay Alspach

Executive Director

Anina Adelfio

Chief Operating Officer

Karen Noonan

Senior Vice President, Global Regulatory Policy

Erin Brown

Director, Industry Intelligence and Messaging

Maddy Sever

Communications & Membership Associate

Fiona Lewis

Advocacy Associate